EX-4.3
from S-1
6 pages
For Value Received, the Undersigned Biohaven Pharmaceutical Holding Company Ltd., a Bvi Business Company Incorporated Under the Laws of the British Virgin Islands (“Borrower”), Promises to Pay to the Order of Wells Fargo Bank, National Association, a National Banking Association (“Bank”), at Its Office at 101 Federal Street, Suite 2020, Boston, Massachusetts, 02110, or at Such Other Place as the Holder Hereof May Designate, in Lawful Money of the United States of America and in Immediately Available Funds, the Principal Sum of Five Million Dollars ($5,000,000), or So Much Thereof as May Be Advanced and Be Outstanding Pursuant to the Terms of the Credit Agreement, as Defined Herein, With Interest Thereon, to Be Computed on Each Advance From the Date of Its Disbursement as Set Forth Herein. Definitions: As Used Herein, the Following Terms Shall Have the Meanings Set Forth After Each, and Any Other Term Defined in This Note Shall Have the Meaning Set Forth at the Place Defined
12/34/56
EX-4.3
from DRS
6 pages
For Value Received, the Undersigned Biohaven Pharmaceutical Holding Company Ltd., a Bvi Business Company Incorporated Under the Laws of the British Virgin Islands (“Borrower”), Promises to Pay to the Order of Wells Fargo Bank, National Association, a National Banking Association (“Bank”), at Its Office at 101 Federal Street, Suite 2020, Boston, Massachusetts, 02110, or at Such Other Place as the Holder Hereof May Designate, in Lawful Money of the United States of America and in Immediately Available Funds, the Principal Sum of Five Million Dollars ($5,000,000), or So Much Thereof as May Be Advanced and Be Outstanding Pursuant to the Terms of the Credit Agreement, as Defined Herein, With Interest Thereon, to Be Computed on Each Advance From the Date of Its Disbursement as Set Forth Herein. Definitions: As Used Herein, the Following Terms Shall Have the Meanings Set Forth After Each, and Any Other Term Defined in This Note Shall Have the Meaning Set Forth at the Place Defined
12/34/56
